RE-BVS – Piemonte Repository

Sfoglia per AUTORE
STEFANI PM
Collezione AOU Alessandria

Items : 5

The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial. in Leukemia / Leukemia. 2026 Jan;40(1):219-223. doi: 10.1038/s41375-025-02795-0. Epub 2025 Nov 7.

2026
AOU Alessandria

Moia R; Ragaini S; Cascione L; Rinaldi A; Genuardi E; Talotta D; Almasri M; Bruscaggin A; Zaccaria GM; Evangelista A; Civita AM; Di Rocco A; Petrucci L; Cavallo F; Celli M; Luppi M; Stelitano C; Stefani PM; Visco C; Billio A; Casaroli I; Castellino C; Pavone E; Galimberti S; Plenteda C; Merli F; Mahmoud AM; Rossi D; Gaidano G; et alii...

Long-term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients. in HemaSphere / Hemasphere. 2025 Mar 22;9(3):e70102. doi: 10.1002/hem3.70102. eCollection 2025 Mar.

2025
AOU Città della Salute di Torino
AOU Alessandria

Luppi M; Stefani PM; Visco C; Puccini B; Ferreri AJM; Ballerini F; Molinari AL; Arcaini L; da Silva MG; Zilioli VR; Balzarotti M; Botto B; Re A; Pagani C; Stefoni V; Di Rocco A; Cavallo F; Zanni M; Mian M; Drandi D; Genuardi E; Evangelista A; Ferrero S; Tavarozzi R; Casaroli I; Stelitano C; Ciccone G; Vitolo U; Martelli M; et alii...

End of induction [(18)F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3311-3321. doi: 10.1007/s00259-024-06765-z. Epub 2024 Ma

2024
AOU Alessandria
AO Cuneo

Usai SV; Vitolo U; Falcinelli F; Gini G; Galimberti S; Roti G; Mannina D; Musto P; Conconi A; Massaia M; Bari A; Califano C; Arcari A; Chiarenza A; Pavone V; Bolis SAM; Bianchi B; Tosi P; Musuraca G; Ladetto M; Barbieri E; Monaco L; Franceschetto A; Peano S; Durmo R; Marcheselli L; Bergesio F; Fallanca F; Chauvie S; et alii...

Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma. in Blood / Blood. 2022 Sep 22;140(12):1378-1389. doi: 10.1182/blood.2021014270.

2022
AOU Alessandria
AOU Città della Salute di Torino

Hohaus S; Re F; Petrini M; Pavone V; Castellino C; Zanni M; Casaroli I; Benedetti F; Stefani PM; De Luca G; Mantoan B; Evangelista A; Ferrante M; Ghislieri M; Alessandria B; Zaccaria GM; Drandi D; Genuardi E; Grimaldi D; Ferrero S; Musuraca G; Cascavilla N; Ghiggi C; Liberati AM; Cortelazzo S; Ladetto M;

Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Jan;8(1):e34-e44. doi: 10.1016/S2352-3026(20)30358-6. Epub 2020 Dec 22.

2021
AOU Alessandria
AOU Città della Salute di Torino

Vitolo U; Martelli M; Stelitano C; Ciccone G; Narni F; Casaroli I; Stefani PM; Puccini B; Benedetti F; Ferreri AJM; Molinari AL; Ballerini F; Arcaini L; Gomes da Silva M; Chiappella A; Zilioli VR; Balzarotti M; Stefoni V; Pagani C; Re A; Di Rocco A; Zanni M; Cavallo F; Mian M; Tavarozzi R; Ferrero S; Evangelista A; Ladetto M; Cortelazzo S; et alii...